NDC properties for NDC 9 50090-6704
NDC item 50090670400
| NDC 9 | 50090-6704 |
|---|---|
| NDC 10 | 50090-6704-0 |
| NDC Item | 50090670400 |
| packaging | 2 SYRINGE in 1 CARTON (50090-6704-0) / .4 mL in 1 SYRINGE |
| BLA | BLA761059 |
| FDA SPL set id | 732799 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
NDC item 78206018601
| NDC 9 | 78206-186 |
|---|---|
| NDC 10 | 78206-186-01 |
| NDC Item | 78206018601 |
| packaging | 2 SYRINGE in 1 CARTON (78206-186-01) / .4 mL in 1 SYRINGE (78206-186-99) |
| BLA | BLA761059 |
| FDA SPL set id | 796818 |
| Labeler | Organon LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
NDC item 78206018699
| NDC 9 | 78206-186 |
|---|---|
| NDC 10 | 78206-186-99 |
| NDC Item | 78206018699 |
| packaging | 0.4 mL in 1 SYRINGE |
| BLA | BLA761059 |
| FDA SPL set id | 796818 |
| Labeler | Organon LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |